Individual Antidepressants and the Risk of Fractures in Older Adults: A New User Active Comparator Study

References

• Wong J, Motulsky A, Abrahamowicz M, Eguale T, Buckeridge DL, Tamblyn R. Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system. BMJ. 2017;356:j603. doi:10.1136/bmj.j60328228380
   PubMed Web of Science ®Google Scholar
• Ufer M, Meyer SA, Junge O, et al. Patterns and prevalence of antidepressant drug use in the German state of Baden-Wuerttemberg: a prescription-based analysis. Pharmacoepidemiol Drug Saf. 2007;16(10):1153–1160. doi:10.1002/pds.140517443868
   PubMed Web of Science ®Google Scholar
• Abbing-Karahagopian V, Huerta C, Souverein PC, et al. Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications. Eur J Clin Pharmacol. 2014;70(7):849–857. doi:10.1007/s00228-00014-01676-z24793010
   PubMed Web of Science ®Google Scholar
• Antidepressants in Patterns of Use of Mental Health Services and Prescription Medications; 2011 Available from: http://www.abs.gov.au/ausstats/[email protected]/Lookup/by%20Subject/4329.0.00.003~2011~Main%20Features~Antidepressants~10008. Accessed 710, 2019.
   Google Scholar
• Hansen DG, Rosholm JU, Gichangi A, Vach W. Increased use of antidepressants at the end of life: population-based study among people aged 65 years and above. Age Ageing. 2007;36(4):449–454. doi:10.1093/ageing/afm05617537746
   PubMed Web of Science ®Google Scholar
• Moore TJ, Mattison DR. Adult utilization of psychiatric drugs and differences by sex, age, and race. JAMA Intern Med. 2017;177(2):274–275. doi:10.1001/jamainternmed.2016.750727942726
   PubMed Web of Science ®Google Scholar
• Carriere I, Farre A, Norton J, et al. Patterns of selective serotonin reuptake inhibitor use and risk of falls and fractures in community-dwelling elderly people: the three-city cohort. Osteoporos Int. 2016;27(11):3187–3195. doi:10.1007/s00198-016-3667-727311722
   PubMed Web of Science ®Google Scholar
• Coupland C, Dhiman P, Morriss R, Arthur A, Barton G, Hippisley-Cox J. Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ. 2011;343(aug02 1):d4551. doi:10.1136/bmj.d455121810886
   PubMed Web of Science ®Google Scholar
• Richards JB, Papaioannou A, Adachi JD, et al. Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med. 2007;167(2):188–194. doi:10.1001/archinte.167.2.18817242321
   PubMedGoogle Scholar
• Ensrud KE, Blackwell T, Mangione CM, et al. Central nervous system active medications and risk for fractures in older women. Arch Intern Med. 2003;163(8):949–957. doi:10.1001/archinte.163.8.94912719205
   PubMedGoogle Scholar
• Moura C, Bernatsky S, Abrahamowicz M, et al. Antidepressant use and 10-year incident fracture risk: the population-based Canadian Multicentre Osteoporosis Study (CaMoS). Osteoporos Int. 2014;25(5):1473–1481. doi:10.1007/s00198-014-2649-x24566587
   PubMed Web of Science ®Google Scholar
• Ziere G, Dieleman JP, van der Cammen TJ, Hofman A, Pols HA, Stricker BH. Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures. J Clin Psychopharmacol. 2008;28(4):411–417. doi:10.1097/JCP.0b013e31817e0ecb18626268
   PubMed Web of Science ®Google Scholar
• Bolton JM, Morin SN, Majumdar SR, et al. Association of mental disorders and related medication use with risk for major osteoporotic fractures. JAMA Psychiatry. 2017;74(6):641–648. doi:10.1001/jamapsychiatry.2017.044928423154
   PubMed Web of Science ®Google Scholar
• Ray WA. Cyclic antidepressants and the risk of hip fracture. Arch Intern Med. 1991;151(4):754–756. doi:10.1001/archinte.1991.004000400960212012459
   PubMedGoogle Scholar
• Liu B, Anderson G, Mittmann N, To T, Axcell T, Shear N. Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Lancet. 1998;351(9112):1303–1307. doi:10.1016/S0140-6736(97)09528-79643791
   PubMed Web of Science ®Google Scholar
• Hubbard R. Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture. Am J Epidemiol. 2003;158(1):77–84. doi:10.1093/aje/kwg11412835289
   PubMed Web of Science ®Google Scholar
• Souverein PC, Abbing-Karahagopian V, Martin E, et al. Understanding inconsistency in the results from observational pharmacoepidemiological studies: the case of antidepressant use and risk of hip/femur fractures. Pharmacoepidemiol Drug Saf. 2016;25(Suppl 1):88–102. doi:10.1002/pds.386227038355
   PubMed Web of Science ®Google Scholar
• Leach MJ, Pratt NL, Roughead EE. Psychoactive medicine use and the risk of hip fracture in older people: a case-crossover study. Pharmacoepidemiol Drug Saf. 2015;24(6):576–582. doi:10.1002/pds.378525879164
   PubMed Web of Science ®Google Scholar
• Bakken MS, Engeland A, Engesaeter LB, Ranhoff AH, Hunskaar S, Ruths S. Increased risk of hip fracture among older people using antidepressant drugs: data from the Norwegian prescription database and the Norwegian hip fracture registry. Age Ageing. 2013;42(4):514–520. doi:10.1093/ageing/aft00923438446
   PubMed Web of Science ®Google Scholar
• Wu Q, Bencaz AF, Hentz JG, Crowell MD. Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case-control studies. Osteoporos Int. 2012;23(1):365–375. doi:10.1007/s00198-011-1778-821904950
   PubMed Web of Science ®Google Scholar
• Wu Q, Qu W, Crowell MD, Hentz JG, Frey KA. Tricyclic antidepressant use and risk of fractures: a meta-analysis of cohort and case-control studies. J Bone Miner Res. 2013;28(4):753–763. doi:10.1002/jbmr.181323165455
   PubMed Web of Science ®Google Scholar
• Eom CS, Lee HK, Ye S, Park SM, Cho KH. Use of selective serotonin reuptake inhibitors and risk of fracture: a systematic review and meta-analysis. J Bone Miner Res. 2012;27(5):1186–1195. doi:10.1002/jbmr.155422258738
   PubMed Web of Science ®Google Scholar
• Oderda LH, Young JR, Asche CV, Pepper GA. Psychotropic-related hip fractures: meta-analysis of first-generation and second-generation antidepressant and antipsychotic drugs. Ann Pharmacother. 2012;46(7–8):917–928. doi:10.1345/aph.1Q58922811347
   PubMed Web of Science ®Google Scholar
• Rabenda V, Nicolet D, Beaudart C, Bruyere O, Reginster JY. Relationship between use of antidepressants and risk of fractures: a meta-analysis. Osteoporos Int. 2013;24(1):121–137. doi:10.1007/s00198-012-2015-922638709
   PubMed Web of Science ®Google Scholar
• Pigeot I, Ahrens W. Establishment of a pharmacoepidemiological database in Germany: methodological potential, scientific value and practical limitations. Pharmacoepidemiol Drug Saf. 2008;17(3):215–223. doi:10.1002/pds.154518200610
   PubMed Web of Science ®Google Scholar
• Schink T, Garbe E. Representativity of dispensations of non-steroidal anti-inflammatory drugs (NSAIDs) in the German pharmacoepidemiological research database. Pharmacoepidemiol Drug Saf. 2010;19:S294–S294.
   Web of Science ®Google Scholar
• Garbe E, Kreisel SH, Behr S. Risk of subarachnoid hemorrhage and early case fatality associated with outpatient antithrombotic drug use. Stroke. 2013;44(9):2422–2426. doi:10.1161/STROKEAHA.111.00081123813986
   PubMed Web of Science ®Google Scholar
• Ohlmeier C, Langner I, Garbe E, Riedel O. Validating mortality in the German Pharmacoepidemiological Research Database (GePaRD) against a mortality registry. Pharmacoepidemiol Drug Saf. 2016;25(7):778–784. doi:10.1002/pds.400527061445
   PubMed Web of Science ®Google Scholar
• Jobski K, Schmedt N, Kollhorst B, Krappweis J, Schink T, Garbe E. Characteristics and drug use patterns of older antidepressant initiators in Germany. Eur J Clin Pharmacol. 2017;73(1):105–113. doi:10.1007/s00228-00016-02145-00227.27752752
   PubMed Web of Science ®Google Scholar
• Schmedt N, Jobski K, Kollhorst B, et al. Treatment patterns and characteristics of older antipsychotic users in Germany. Int Clin Psychopharmacol. 2016;31(3):159–169. doi:10.1097/YIC.000000000000011926871678
   PubMed Web of Science ®Google Scholar
• Schmedt N, Garbe E. Antipsychotic drug use and the risk of venous thromboembolism in elderly patients with dementia. J Clin Psychopharmacol. 2013;33(6):753–758. doi:10.1097/JCP.0b013e3182a412d524052055
   PubMed Web of Science ®Google Scholar
• Schroder C, Dorks M, Kollhorst B, et al. Extent and risks of antidepressant off-label use in children and adolescents in Germany between 2004 and 2011. Pharmacoepidemiol Drug Saf. 2017;26(11):1395–1402. doi:10.1002/pds.428928840629
   PubMed Web of Science ®Google Scholar
• Pisa FE, Reinold J, Kollhorst B, Haug U, Schink T. Antidepressants and the risk of traumatic brain injury in the elderly: differences between individual agents. Clin Epidemiol. 2019;11:185–196. doi:10.2147/CLEP.S17366730858730
   PubMed Web of Science ®Google Scholar
• Lund JL, Richardson DB, Sturmer T. The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application. Curr Epidemiol Rep. 2015;2(4):221–228. doi:10.1007/s40471-015-0053-526954351
   PubMedGoogle Scholar
• Leach MJ, Pratt NL, Roughead EE. The risk of hip fracture due to mirtazapine exposure when switching antidepressants or using other antidepressants as add-on therapy. Drugs Real World Outcomes. 2017;4(4):247–255. doi:10.1007/s40801-017-0120-y28940138
   PubMedGoogle Scholar
• Rothman K, Greenland S, Lash C. Case-control studies In: Rothman K, Greenland S, Lash C, editors. Modern Epidemiology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2008:111–127.
   Google Scholar
• Gardarsdottir H, Souverein PC, Egberts TC, Heerdink ER. Construction of drug treatment episodes from drug-dispensing histories is influenced by the gap length. J Clin Epidemiol. 2010;63(4):422–427. doi:10.1016/j.jclinepi.2009.07.00119880282
   PubMed Web of Science ®Google Scholar
• Gardarsdottir H, Heerdink ER, Egberts AC. Potential bias in pharmacoepidemiological studies due to the length of the drug free period: a study on antidepressant drug use in adults in the Netherlands. Pharmacoepidemiol Drug Saf. 2006;15(5):338–343. doi:10.1002/pds.122316496430
   PubMed Web of Science ®Google Scholar
• Deandrea S, Lucenteforte E, Bravi F, Foschi R, La Vecchia C, Negri E. Risk factors for falls in community-dwelling older people: a systematic review and meta-analysis. Epidemiology. 2010;21(5):658–668. doi:10.1097/EDE.0b013e3181e8990520585256
   PubMed Web of Science ®Google Scholar
• Johnell K, Jonasdottir Bergman G, Fastbom J, Danielsson B, Borg N, Salmi P. Psychotropic drugs and the risk of fall injuries, hospitalisations and mortality among older adults. Int J Geriatr Psychiatr. 2017;32(4):414–420. doi:10.1002/gps.4483
   PubMed Web of Science ®Google Scholar
• Ensrud KE, Blackwell TL, Mangione CM, et al. Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc. 2002;50(10):1629–1637. doi:10.1046/j.1532-5415.2002.50453.x12366615
   PubMed Web of Science ®Google Scholar
• van Doorn C, Gruber-Baldini AL, Zimmerman S, et al. Dementia as a risk factor for falls and fall injuries among nursing home residents. J Am Geriatr Soc. 2003;51(9):1213–1218. doi:10.1046/j.1532-5415.2003.51404.x12919232
   PubMed Web of Science ®Google Scholar
• Tolppanen A-M, Lavikainen P, Soininen H, Hartikainen S, Kado D. Incident hip fractures among community dwelling persons with Alzheimer’s disease in a Finnish nationwide register-based cohort. PLoS One. 2013;8(3):e59124. doi:10.1371/journal.pone.005912423527106
   PubMed Web of Science ®Google Scholar
• Park H, Satoh H, Miki A, Urushihara H, Sawada Y. Medications associated with falls in older people: systematic review of publications from a recent 5-year period. Eur J Clin Pharmacol. 2015;71(12):1429–1440. doi:10.1007/s00228-015-1955-326407688
   PubMed Web of Science ®Google Scholar
• Richardson K, Bennett K, Kenny RA. Polypharmacy including falls risk-increasing medications and subsequent falls in community-dwelling middle-aged and older adults. Age Ageing. 2015;44(1):90–96. doi:10.1093/ageing/afu14125313240
   PubMed Web of Science ®Google Scholar
• Reyes C, Estrada P, Nogues X, et al. The impact of common co-morbidities (as measured using the Charlson index) on hip fracture risk in elderly men: a population-based cohort study. Osteoporos Int. 2014;25(6):1751–1758. doi:10.1007/s00198-014-2682-924676845
   PubMed Web of Science ®Google Scholar
• Beydoun HA, Beydoun MA, Mishra NK, Rostant OS, Zonderman AB, Eid SM. Comorbid Parkinson’s disease, falls and fractures in the 2010 National Emergency Department Sample. Parkinsonism Relat Disord. 2017;35:30–35. doi:10.1016/j.parkreldis.2016.11.00527887896
   PubMed Web of Science ®Google Scholar
• Koponen M, Taipale H, Lavikainen P, et al. Antipsychotic use and the risk of hip fracture among community-dwelling persons with Alzheimer’s disease. J Clin Psychiatr. 2017;78(3):e257–e263. doi:10.4088/JCP.15m10458
   Web of Science ®Google Scholar
• McConeghy KW, Lee Y, Zullo AR, et al. Influenza illness and hip fracture hospitalizations in nursing home residents: are they related? J Gerontol a Biol Sci Med Sci. 2017;73(12):1638–1642.
   Web of Science ®Google Scholar
• Noguchi N, Chan L, Cumming RG, Blyth FM, Naganathan V. A systematic review of the association between lower urinary tract symptoms and falls, injuries, and fractures in community-dwelling older men. Aging Male. 2016;19(3):168–174. doi:10.3109/13685538.2016.116939927068237
   PubMed Web of Science ®Google Scholar
• Parsons JK, Mougey J, Lambert L, et al. Lower urinary tract symptoms increase the risk of falls in older men. BJU Int. 2009;104(1):63–68. doi:10.1111/j.1464-410X.2008.08317.x19154508
   PubMed Web of Science ®Google Scholar
• Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676–682. doi:10.1093/aje/kwq43321330339
   PubMed Web of Science ®Google Scholar
• Schneeweiss S, Wang PS. Association between SSRI use and hip fractures and the effect of residual confounding bias in claims database studies. J Clin Psychopharmacol. 2004;24(6):632–638. doi:10.1097/01.jcp.0000145344.76288.3915538126
   PubMed Web of Science ®Google Scholar
• Aronson JK. Meyler’s Side Effects of Drugs. The International Encyclopedia of Adverse Drug Reactions and Interactions. 16th Elsevier Science 2015.
   Google Scholar
• Darowski A, Chambers SA, Chambers DJ. Antidepressants and falls in the elderly. Drugs Aging. 2009;26(5):381–394. doi:10.2165/00002512-200926050-0000219552490
   PubMed Web of Science ®Google Scholar
• Sultana J, Spina E, Trifiro G. Antidepressant use in the elderly: the role of pharmacodynamics and pharmacokinetics in drug safety. Expert Opin Drug Metab Toxicol. 2015;11(6):883–892. doi:10.1517/17425255.2015.102168425736834
   PubMed Web of Science ®Google Scholar
• Thorlund K, Druyts E, Wu P, Balijepalli C, Keohane D, Mills E. Comparative efficacy and safety of selective serotonin reuptake inhibitors and serotonin‐norepinephrine reuptake inhibitors in older adults: a network meta‐analysis. J Am Geriatr Soc. 2015;63(5):1002–1009. doi:10.1111/jgs.1339525945410
   PubMed Web of Science ®Google Scholar
• Gillman PK. Tricyclic antidepressant pharmacology and therapeutic drug interactions updated. Br J Pharmacol. 2007;151(6):737–748. doi:10.1038/sj.bjp.070725317471183
   PubMed Web of Science ®Google Scholar
• Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol. 2005;58(4):323–337. doi:10.1016/j.jclinepi.2004.10.01215862718
   PubMed Web of Science ®Google Scholar
• Clement ND, Court-Brown CM. Elderly pelvic fractures: the incidence is increasing and patient demographics can be used to predict the outcome. Eur J Orthop Surg Traumatol. 2014;24(8):1431–1437. doi:10.1007/s00590-014-1439-724664452
   PubMedGoogle Scholar
• Court-Brown CM, McQueen MM. Global forum: fractures in the elderly. J Bone Joint Surg Am. 2016;98(9):e36. doi:10.2106/JBJS.15.0079327147693
   PubMed Web of Science ®Google Scholar
• Seppala LJ, Wermelink A, de Vries M, et al. Fall-risk-increasing drugs: a systematic review and meta-analysis: II. Psychotropics. J Am Med Dir Assoc. 2018;19(4):371e311–371 e317.
   Web of Science ®Google Scholar
• Fink HA, Milavetz DL, Palermo L, et al. What proportion of incident radiographic vertebral deformities is clinically diagnosed and vice versa? J Bone Miner Res. 2005;20(7):1216–1222. doi:10.1359/JBMR.05031415940375
   PubMed Web of Science ®Google Scholar
• Delmas PD, van de Langerijt L, Watts NB, et al. Underdiagnosis of vertebral fractures is a worldwide problem: the IMPACT study. J Bone Miner Res. 2005;20(4):557–563. doi:10.1359/JBMR.04121415765173
   PubMed Web of Science ®Google Scholar
• Ensrud KE, Blackwell TL, Fink HA, et al. What proportion of incident radiographic vertebral fractures in older men is clinically diagnosed and vice versa: a prospective study. J Bone Miner Res. 2016;31(8):1500–1503. doi:10.1002/jbmr.283126969847
   PubMed Web of Science ®Google Scholar